IL2 and cancer: In this secondary analysis of our randomized controlled CRBP-TS trial, we evaluated the effects of HOET on the cytokines IL-1ß, IL-2, IL-6, IL-10, IL-12p70, TNF-α, IFN-γ, and the mGPS of 145 cancer patients.